Connect with us

Hi, what are you looking for?

Medicine

Cytokinetics Announces Four Presentations at the 32nd International Symposium on ALS/MND

SOUTH SAN FRANCISCO, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (NASDAQ:CYTK) today announced one oral presentation and three poster presentations at the 32nd International Symposium on ALS/MND taking place online from December 7 – December 10, 2021.

Oral Presentation

Session Title: Session 5: Autonomy and Decision Making
Presentation Title: IMPACT ALS Europe – a European Survey of People Living with ALS
Presenter: Mark Heverin, Research Manager, Academic Unit of Neurology, Trinity College Dublin
Presentation Number: C14
Date: December 8, 2021
Session Time: 4:50 – 6:00 PM GMT
Presentation Time: 5:30 – 5:45 PM GMT

Poster Presentations

Session Title: Live Poster Session A
Theme: 09 – Clinical Trials and Trial Design
Presentation Title: Relationship Between Quantitative Strength Changes and Functional Outcomes in the Phase 2 FORTITUDE-ALS Trial
Presenter: Bill Jacobsen, M.D., Neurologist, Gregory W. Fulton ALS and Neuromuscular Disease Center and Assistant Professor, Department of Neurology at the Barrow Neurological Institute
Poster Number: CLT-10
Date: December 7, 2021
Session Time: 4:50 – 6:20 PM GMT

Session Title: Live Poster Session A
Theme: 09 – Clinical Trials and Trial Design
Presentation Title: Update of COURAGE-ALS: A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Study to Evaluate Efficacy and Safety of Reldesemtiv in Patients with ALS
Presenter: Stacy Rudnicki, M.D., Vice President, Clinical Research, Cytokinetics
Poster Number: CLT-15
Date: December 7, 2021
Session Time: 4:50 – 6:20 PM GMT

Session Title: Live Poster Session C
Theme: 09 – Clinical Trials and Trial Design
Presentation Title: Grip Strength is More than a Number: The Relationship Between Grip Strength and Fine Motor and Arm Function in FORTITUDE-ALS
Presenter: Andrew …

Full story available on Benzinga.com

Source: benzinga.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Medicine

Arbutus’ Lead Compound AB-729 Continues to be Safe and Effective at Reducing HBsAg in Patients with Chronic Hepatitis B HBsAg remains suppressed up to...

Arts

The Fourth Single ‘Eyy Bidda Idhi Naa Adda’ From Allu Arjun’s Pushpa Is Out… The Fourth Single ‘Eyy Bidda Idhi Naa Adda’ From Allu...

Arts

Kyle Rittenhouse testifies about Gaige Grosskreutz holding a gun toward him during his trial at the Kenosha County Courthouse on November 10, 2021 in...

Medicine

PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC, the “Company”)), a biotechnology company with operations in China and the...

ONBP.com